AmeriFlex Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$381K Sell
1,558
-469
-23% -$109K 0.19% 112
2025
Q4
$419K Sell
2,027
-1,942
-49% -$384K 0.22% 101
2025
Q3
$736K Sell
3,969
-1,259
-24% -$216K 0.28% 70
2025
Q2
$795K Sell
5,228
-1,769
-25% -$272K 0.42% 53
2025
Q1
$1.16M Buy
6,997
+3,381
+94% +$529K 0.47% 48
2024
Q4
$550K Buy
+3,616
New +$560K 0.25% 89

Other funds holding JNJ

AmeriFlex Group's JNJ Position: Q1 2026 in Review

AmeriFlex Group reduced its Johnson & Johnson (JNJ) stake by 23% in Q1 2026, selling an estimated $109K and leaving 1,558 shares worth $381K. The position accounts for 0.19% of the portfolio, ranked #112.

AmeriFlex Group first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.16M in Q1 2025. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • AmeriFlex Group held 1,558 shares of Johnson & Johnson worth $381K as of Q1 2026.
  • AmeriFlex Group sold 469 Johnson & Johnson shares in Q1 2026, an estimated $109K.
  • Johnson & Johnson made up 0.19% of AmeriFlex Group's portfolio in Q1 2026, its #112 holding.
  • AmeriFlex Group first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • AmeriFlex Group's Johnson & Johnson position peaked at $1.16M in Q1 2025.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.